E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/3/2003 in the Prospect News Convertibles Daily.

ViroPharma buys back $45.1 million convertibles

New York, Jan. 3 - ViroPharma Inc. said it bought back $45.1 million principal amount of its outstanding 6% convertible subordinated notes due 2007 at an average price of 37.

The Exton, Pa. pharmaceutical company said it now has $134.9 million of the convertibles outstanding.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.